drug
Entresto
Marketedupdated 3mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Entresto
- phase1Bioequivalence Study of Valsatril Tablet Versus Entresto® (Sacubitril/Valsartan 24/26mg) 24mg/26mg Tablet.
- —Special Drug Use Surveillance of Entresto Tablets (Hypertension)
- phase2Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019
- phase1A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
- phase1A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
- phase1A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
News(4)
- STAT+: PBMs agree to display TrumpRx drug pricesBristol's Zenbexus wins accelerated approval, Novartis wins UK patent fight over Entresto, and more biotech news from The Readoutstat · 2h ago
- Novartis climbs on upbeat drug sales as key readouts loomA return to quarterly sales growth boosted shares higher on Tuesday, though a handful of coming study results will have a bigger impact on the company’s long-term outlook.biopharma_dive · 24d ago
- Novartis stays 'geography-agnostic' in dealmaking amid flurry of China dealsNovartis will continue to be on the lookout for bolt-on deals below $2 billion, CEO Vas Narasimhan said Tuesday on the pharma's second quarter earnings call—though major pickups aren’t completely o…biospace · 24d ago
- STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data neededEli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news todaystat · 3mo ago
Data sources
last refreshed 47m ago
Found something off?
comments(0)
5-min edit window · permanent after that